Shift­ing fo­cus, Sanofi agrees to pay Re­gen­eron $462M for an ear­ly wrap of their big I/O al­liance

Sanofi has agreed to hand $462 mil­lion to Re­gen­eron for an ear­ly wrap to their im­muno-on­col­o­gy al­liance, nar­row­ly lim­it­ing an R&D re­la­tion­ship that will now con­cen­trate on 2 lead pro­grams in the clin­ic and leav­ing each of the com­pa­nies free to pur­sue their own fates in I/O as they move to be­gin shut­ter­ing one of the in­dus­try’s most pro­duc­tive de­vel­op­ment al­liances.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER